PMCF Study on Comparison of EDOF Lenses (Switzerland)

Inclusion Criteria: * Cataractous eyes with no comorbidity; * Calculated IOL power is within the range of the study IOLs; * Male or female adults ages 50 years or older on the day of screening who have cataract(s) in one or both eyes; * Regular total corneal astigmatism ≤1.0 D (measured by topography method) * Clear intraocular media other than cataract; * Availability, willingness and sufficient cognitive awareness to comply with examination procedures; * Expected postoperative Best Corrected Distance Visual Acuity (CDVA) ≤ 0.2 logMAR; * Signed informed consent. Exclusion Criteria: * Age of patient \< 50 years; * Regular total corneal astigmatism \>1.0 dioptres (measured by topography method) * Irregular astigmatism; * Difficulty for cooperation (distance from their home, general health conditions); * Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal or optic disorders); * Subjects who may be expected to require retinal laser treatment during the course of the study or at a greater risk of developing cystoid macular edema or macula pucker; * Previous intraocular or corneal surgery or intravitreal injection; * Traumatic cataract; * History or presence of macular edema; * Glaucoma with visual field defects; * Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic / scotopic conditions); * Amblyopia with monocular preoperative CDVA of \>0.1 logMAR; * Cornea guttata; * Keratoconus; * Chronic uveitis; * Expected complicated surgery; * Significant dry eye; * Contra-indications as listed in the current Instructions for use (IFU); * Contra-indication or unwillingness to perform immediate sequential bilateral cataract surgery; * Concurrent or previous (within 60 days) participation in another drug or device investigation. In addition to above mentioned in- and exclusion criteria, subjects shall be discontinued when certain conditions are present at the time of surgery, including: * zonular instability or defect; * capsular fibrosis or other opacity; and * inability to fixate IOL in desired position. In such cases, the subject shall be followed until the condition has stabilized.